FM
CLVS

Forward Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Forward Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-60,314
Closed -$5.27M – 310
2015
Q2 		$5.27M Buy
60,314
+30,289
+101% +$2.59M 0.32% 54
2015
Q1 		$2.13M Buy
30,025
+602
+2% +$42.5K 0.13% 105
2014
Q4 		$1.17M Sell
29,423
-21,235
-42% -$1.12M 0.06% 157
2014
Q3 		$1.95M Buy
50,658
+19,715
+64% +$824K 0.12% 112
2014
Q2 		$1.1M Buy
30,943
+7,830
+34% +$403K 0.06% 141
2014
Q1 		$1.18M Sell
23,113
-12,167
-34% -$894K 0.07% 136
2013
Q4 		$1.96M Buy
35,280
+2,100
+6% +$114K 0.12% 103
2013
Q3 		$1.85M Buy
33,180
+9,030
+37% +$640K 0.12% 105
2013
Q2 		$1.26M Buy
+24,150
New +$1.09M 0.1% 133

Other funds holding CLVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Forward Management's CLVS Position: Q3 2015 in Review

Forward Management sold out of Clovis Oncology, Inc. (CLVS) in Q3 2015, closing a stake of 60,314 shares — an estimated $5.27M sold.

Forward Management first reported a position in CLVS in Q2 2013 and held it in 9 quarters. The position peaked at $5.27M in Q2 2015. 192 funds tracked by Wall St. Rank hold CLVS as of Q3 2015.

  • Forward Management reported no remaining Clovis Oncology, Inc. position as of Q3 2015 after selling out during the quarter.
  • Forward Management sold 60,314 Clovis Oncology, Inc. shares in Q3 2015, an estimated $5.27M.
  • Forward Management first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 9 quarters.
  • Forward Management's Clovis Oncology, Inc. position peaked at $5.27M in Q2 2015.
  • 192 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2015.

Based on Forward Management's 13F filing for Q3 2015, filed 9 Nov 2015.